298. Hereditary pancreatitis Clinical trials / Disease details

Clinical trials : 95 / Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00401076 (ClinicalTrials.gov)	July 2008	16/11/2006	A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency	A One-year Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy	Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy	Drug: SA -001	Abbott	NULL	Completed	20 Years	N/A	Both	80	Phase 3	Japan
2	NCT00400842 (ClinicalTrials.gov)	May 2007	16/11/2006	A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency	A Double-blind, Placebo-controlled, Parallel-group, Comparative Study to Confirm the Safety and Efficacy of Oral 1.5 g/Day and 3.0 g/Day of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy	Exocrine Pancreatic Insufficiency, Chronic Pancreatitis	Drug: SA -001;Drug: Placebo	Abbott	NULL	Completed	20 Years	N/A	Both	274	Phase 3	Japan